Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $991 thousand versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.